Kindred Biosciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Kindred Biosciences's past years’ income statements indicate that its last revenue has increased compared to the previous period by 891% to $42,164,000. The net income raised on -$23,624,000 and profit margin reached -56%. Total operating expenses were $53,260,000.

Profit Margin

Kindred Biosciences, Inc. (NASDAQ:KIN): Profit margin
2012 0 -120K
2013 0 -4.21M
2014 0 -27.13M
2015 0 -27.13M
2016 0 -22.49M
2017 0 -30.87M
2018 1.96M -49.69M -2527.47%
2019 4.25M -61.38M -1442.41%
2020 42.16M -23.62M -56.03%

KIN Income Statement (2012 – 2020)

2020 2019 2018 2017 2016 2015 2014 2013 2012
Revenue
Revenue
42.16M4.25M1.96M000000
Cost of revenue
4.62M587K324K000000
Gross profit
37.53M3.66M1.64M000000
Operating exp.
Research and development
31.28M28.31M26.39M17.66M13.86M19.41M18.69M3.14M75K
Selling and marketing
004.42M2.08M1.46M992K000
Total operating expenses
53.26M66.23M52.89M31.65M22.16M27.26M27.23M4.21M120K
Operating income
-19.96M-61.38M-49.69M-30.87M-22.49M-27.13M-27.13M-4.21M-120K
Other income (expenses), net
-1.82M000000-560
Income before tax
-21.79M-61.38M-49.69M-30.87M-22.49M-27.13M-27.13M-4.21M-120K
Income tax expense
1.82M000000560
Net income
-23.62M-61.38M-49.69M-30.87M-22.49M-27.13M-27.13M-4.21M-120K
Earnings per share
Basic EPS
-0.6-1.59-1.6-1.23-1.13-1.37-1.44-1.13-0.02
Diluted EPS
-0.6-1.59-1.6-1.23-1.13-1.37-1.44-1.13-0.02
Data sourceData sourceData sourceData sourceData sourceData sourceData source